Commentary: Methodological considerations in the interpretation of evidence on cannabis-based medicines for chronic neuropathic pain
Wellington Briques, Débora Maria Russiano Pereira, Aderbal Silva Aguiar Junior · 2026
Read Commentary: Methodological considerations in the interpretation of evidence on cannabis-based medicines for chronic neuropathic pain by Wellington Briques, Débora Maria Russiano Pereira, Aderbal Silva Aguiar Junior (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13214087.txt.
Description
Wellington Briques, Débora Maria Russiano Pereira, and Aderbal Silva Aguiar Junior write in 2026 a commentary on how reviewers judge cannabis-based medicines for long-lasting nerve pain. Major reviews call the certainty of benefit low, and the authors accept that verdict while questioning how it gets communicated.
They examine the grading framework reviewers use, the mixing of unlike patients and products, the choice of outcomes, and how directly trial evidence matches real practice. Inconsistent or opaque grading can tilt readers toward overstating or dismissing real effects, they argue. Neuropathic pain trials are short and varied, so context-aware reading matters before clinicians or patients draw conclusions either way.
Catalog record
| CREATOR | Wellington Briques, Débora Maria Russiano Pereira, Aderbal Silva Aguiar Junior |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 11 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |